-
Modner claims that the company has reached a joint agreement with Mitsubishi Tanabe Pharmaceuticals to promote the company's mRNA respiratory vaccine portfolio in Japan
Modner stated that the company has reached a joint agreement with Mitsubishi Tanabe Pharmaceuticals to promote the company's mRNA respiratory vaccine portfolio in Japan. -
Johnson&Johnson Opsynvi single tablet combination therapy approved by FDA
Johnson&Johnson announced on the 23rd that the US FDA has approved its Opsynvi monotherapy combination therapy for long-term treatment of adult patients with pulmonary arterial hypertension (PAH) cla ... -
Exploring the "Golden Nine Silver Ten" in the Car Market: Car Companies Play a Promotion Combination Fist, and New Energy Sales Continuously Rise
Reported by Xia Zhibin, a journalist from our newspaper, from Quartz Jing in Shanghai This car is very popular now. From September 12th to the last day of National Day, in nearly a month, our nationa ...